Oral Contraceptives, Sex, Pregnancy and Breast Feeding in Inflammatory Bowel Disease

Oral Contraceptives, Sex, Pregnancy and Breast Feeding in Inflammatory Bowel Disease

This paper summarizes the scientific basis for advice to inflammatory bowel disease patients concerning oral contraceptives, sex, pregnancy and breast feeding. The physician counselling any individual patient must clearly convert this information into a format suitable for that patient and his famil...

Full description

Bibliographic Details
Main Author:	RN Allan
Format:	Article
Language:	English
Published:	Hindawi Limited 1990-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1990/490182

Similar Items

Inflammatory Bowel Disease, the Oral Contraceptive Pill and Pregnancy
by: Robert N Allan
Published: (1994-01-01)

The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases
by: Santosh Sanagapalli, et al.
Published: (2018-07-01)

Insights into the treatment of inflammatory bowel disease in pregnancy
by: Sarah E. Shannahan, et al.
Published: (2019-05-01)

Pregnancy outcomes of women with inflammatory bowel disease
by: Tunc Bilge, et al.
Published: (2013-01-01)

The effects of oral contraceptives on sex chromatin
by: Chafouleas, James Gus, 1948-
Published: (1973)

Ectopic Pregnancy With Oral Contraceptive Use
by: Hung-Hung Lin, et al.
Published: (2008-09-01)

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
by: Heather A Boyd, et al.
Published: (2015-01-01)

Managing inflammatory bowel disease in pregnancy: current perspectives
by: Pinder M, et al.
Published: (2016-10-01)

Concerns in pregnancy and childbirth of women with inflammatory bowel disease
by: Sung-Ae Jung
Published: (2016-04-01)

Influence of Sex and Disease on Illness-Related Concerns in Inflammatory Bowel Disease
by: R Maunder, et al.
Published: (1999-01-01)

Sex-based differences in inflammatory bowel diseases: a review
by: Sheila D. Rustgi, et al.
Published: (2020-04-01)

Is safety infliximab during pregnancy in patients with inflammatory bowel disease?
by: Federico Argüelles-Arias, et al.

Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease
by: Yu Hsueh Wu, et al.
Published: (2015-07-01)

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
by: Wunan Zhang, et al.
Published: (2021-06-01)

ORAL MUCOSA LESIONS AND ORAL SYMPTOMS IN INFLAMMATORY BOWEL DISEASE PATIENTS
by: Nuno LARANJEIRA, et al.
Published: (2015-06-01)

The influence of pregnancy and oral contraceptive steroids on drug metabolism
by: Neale, Michael Gordon
Published: (1970)

Assessment of nutritional status and feeding methods in patients with inflammatory bowel disease
by: Ewelina Swora-Cwynar, et al.
Published: (2015-09-01)

Current aspects with regard to the link between pregnancy and inflammatory bowel disease
by: Prelipcean Cijevschi Cristina, et al.
Published: (2014-01-01)

Inflammatory Bowel Disease and Pregnancy: Evidence, Uncertainty and Patient Decision-Making
by: Flavio M Habal, et al.
Published: (2009-01-01)

LHRH agonist buserelin : contraception for breast feeding mothers
by: Dewart, P. J.
Published: (1991)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Synthesis and Analysis of Novel Anti-Inflammatory Conjugates for the Treatment of Inflammatory Bowel Disease
by: Bailey, Mark Allan
Published: (2007)

Inflammatory Bowel Disease in Newborn Pigs: The Role of Formula-Feeding and Premature Birth
by: Schmidt Mette, et al.
Published: (2003-03-01)

Prescribing Oral Contraceptives in Women With Breast Diseases: A Matter of Concern for the Gynecologist
by: Sadaf Alipour, et al.
Published: (2019-05-01)

Knowledge translation dataset: An e-health intervention for pregnancy in inflammatory bowel disease
by: Reed T. Sutton, et al.
Published: (2019-04-01)

Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines
by: V. Huang, et al.
Published: (2016-01-01)

Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin
by: Ira Shafran, et al.
Published: (2015-11-01)

Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
by: Marcel Vetter, et al.
Published: (2017-10-01)

The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease
by: P. Rutgeerts
Published: (1998-01-01)

INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012-01-01)

Inflammatory Bowel Disease
Published: (2012)

Inflammatory Mediators in Inflammatory Bowel Disease
by: BM Peskar
Published: (1990-01-01)

Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
by: Afshin A. Divani, et al.
Published: (2015-01-01)

Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
by: Bruno Laganà, et al.
Published: (2019-01-01)

Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease
by: Jing Shao, et al.
Published: (2021-08-01)

Prolonged treatment of combined oral contraceptive: a focus on the prevention of inflammatory diseases of the pelvic organs
by: N I Tapilskaya, et al.
Published: (2017-02-01)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01)

Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan
by: Faezeh Khozeimeh, et al.
Published: (2021-01-01)

Non-contraceptive benefits of oral contraceptives
by: Dhont M
Published: (2011-10-01)

Cannot write session to /tmp/vufind_sessions/sess_9od601f04t1k3ho738t0r3t6oj